SREBF2 and colorectal carcinoma: Notably, hyperactivation of the cholesterol synthesis pathway facilitates CRC liver metastasis, where hepatocyte growth factor (HGF) in the hepatic niche activates PI3K/AKT/mTOR-SREBP2 signaling (134).